Company Overview of Ikano Therapeutics Inc.
As of November 22, 2010, Ikano Therapeutics Inc. went out of business. Ikano Therapeutics Inc., a specialty pharmaceutical company, focuses on developing nasal spray drug products to treat pain and central nervous system disorders. It develops hydro morphone, which is used to treat acute and moderate-to-severe pain; and midazolam that is used for the treatment of epileptic seizures. Ikano Therapeutics Inc. was formerly known as Intranasal Therapeutics, Inc. The company was founded in 1998 and is based in Montvale, New Jersey.
210 Summit Avenue
Montvale, NJ 07645
Founded in 1998
Key Executives for Ikano Therapeutics Inc.
Ikano Therapeutics Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Navitas Pharma, Inc.||United States|
|Targesome, Inc.||United States|
|Apothogen, Inc.||United States|
|Novartis Finance Corporation||United States|
|Watson Laboratories, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ikano Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.